Influenza, Human: all 2,265 studies

Page 13 of 23. Open to participants first (174), then studies with results posted, then the rest; newest registration first within each.

• Immune Response to Influenza Vaccine in ESRD PatientsCompletedNCT04122222Not applicable
• Retrospective Observational Study on the Epidemiological Characteristics of Influenza PatientsStatus unknownNCT04110990
• B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older AdultsActive, not recruitingNCT04101838Phase 4
• Immunogenicity and Safety Evaluation of QIS in Healthy SubjectsCompletedNCT04101435Phase 3
• Factors Influencing Flu Vaccination in Primary Health CareCompletedNCT04097197Not applicable
• Evaluation of the Safety and Immunogenicity of Simultaneously Administration of EV71 Vaccine and Influenza VaccineCompletedNCT04091880Phase 4
• Influenza Vaccine in Children With AsthmaStatus unknownNCT04086628
• Functional Consequences of T-bet Expression in Flu-specific Memory B Cells After Live Attenuated Influenza Vaccine (LAIV)CompletedNCT04080245Early Phase 1
• Clinical and Prognostic Comparisons Between Invasive Pulmonary Aspergillosis With or Without Invasive Tracheobronchitis During Severe Influenza: a Retrospective Multicenter Cohort Study.CompletedNCT04077697
• Safety and Immunogenicity of Hexavalent Vaccine(DTwP-HepB-IPV-Hib) in Healthy InfantsStatus unknownNCT04073459Phase 2
• Impact of Influenza/RSV PCR Point-of-care Testing in the Emergency Medical Service.Status unknownNCT04048369Not applicable
• Norketotifen for the Treatment of Uncomplicated Influenza-like IllnessCompletedNCT04043923Phase 2
• Financing Strategies of Influenza Vaccination in ChinaCompletedNCT04038333
• Study of VIR-2482 in Healthy VolunteersCompletedNCT04033406Phase 1
• Study of ZSP1273 in Patients With Acute Uncomplicated Influenza ACompletedNCT04024137Phase 2
• Study of Influenza Virus Infection in Children Hospitalized in Spain in Two Consecutive Influenza SeasonsCompletedNCT04008823
• Vaccination Against Influenza to Prevent Cardiovascular Events After Acute Coronary SyndromesCompletedNCT04001504Phase 3
• Recombinant Influenza Vaccination in U.S. Nursing HomesStatus unknownNCT03965195Phase 4
• VSMART (Video-Conference Stress Management and Relaxation Training for Older Women With Breast Cancer)CompletedNCT03955991Phase 4
• Evaluate the Safety and Efficacy of Xiyanping in Pediatric Participants With Severe Influenza-Like SymptomsStatus unknownNCT03947411Not applicable
• The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 WeeksCompletedNCT03931239Not applicable
• Pregnancy, Arsenic and Immune ResponseCompletedNCT03930017
• Safety and Immunogenicity of the Butantan Quadrivalent Influenza VaccineCompletedNCT03927131Phase 3
• Safety Study of Live Attenuated Influenza Vaccine, CodaVaxCompletedNCT03926416Phase 1
• Novel Assays for Detection of Influenza VirusWithdrawnNCT03924284
• Evaluation of the Safety and Efficacy of a Monoclonal Antibody to Treat InfluenzaWithdrawnNCT03903718Phase 2
• Adjunctive Sirolimus and Oseltamivir Versus Oseltamivir Alone for Treatment of InfluenzaActive, not recruitingNCT03901001Phase 3
• Prophylactic Treatment With OseltamivirCompletedNCT03899571Not applicable
• Response to Inactivated Influenza Vaccine in Lymph Tissue and BloodWithdrawnNCT03898973Phase 4
• Influenza A+B Test Kit Performance StudyStatus unknownNCT03895268
• Safety, Tolerability and Immunogenicity of an Trivalent Inactivated Cell-Culture Influenza Vaccine in Healthy AdultsCompletedNCT03893669Phase 1
• Response to Live Attenuated Influenza Vaccine in Tonsillar Tissues and BloodWithdrawnNCT03884296Phase 4
• Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml)CompletedNCT03859141Phase 3
• Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (15µg/0.5ml)CompletedNCT03853993Phase 3
• Mucosal and Systemic Immunity After Viral Challenge of Healthy Volunteers Vaccinated With Inactivated Influenza Vaccine Via the Intranasal Versus Intramuscular RouteCompletedNCT03845231Phase 2
• Pre-Approval Access to Pimodivir for the Treatment of Patients With H7N9 Influenza A InfectionNo longer availableNCT03834376
• Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVICompletedNCT03830905Phase 2
• A Randomized, Double-blind, Placebo-controlled, Multicenter and Phase Ⅱa Clinical Trial for the Effectiveness and Safety of Baicalein Tablets in the Treatment of Improve Other Aspects of Healthy Adult With Influenza FeverStatus unknownNCT03830684Phase 2
• Safety, Tolerability and Immunogenicity of NBP607QIV in Healthy Adult VolunteersCompletedNCT03826719Phase 1/2
• Immunomodulatory Effect of Macrolides in Naturally Occurring Influenza Virus Infections in the CommunitySuspendedNCT03824847Phase 4
• Nasal Swab Home Collection Kit (NSHC Kit) StudyCompletedNCT03813966
• Reactogenicity, Safety and Immunogenicity of an Universal Influenza Vaccine UnifluStatus unknownNCT03789539Phase 1
• Severe Influenza Trial of ARbidolCompletedNCT03787459Phase 3
• A Phase 2, Double-blind Study to Evaluate Intranasal Trivalent Influenza Virus Vaccine in Healthy AdultCompletedNCT03784885Phase 2
• Safety and Immunogenicity of the Butantan Institute Influenza Vaccine Compared to Sanofi Pasteur Influenza VaccineCompletedNCT03777163Phase 4
• Nudging for Vaccination : Efficacity and Acceptability Among Medical StudentsCompletedNCT03768596Not applicable
• Safety of a Quadrivalent Influenza Vaccine (VaxigripTetra™) in Subjects Aged 6 Months and Older in VietnamCompletedNCT03765437Phase 3
• Extra-pulmonary Clinical Manifestations of Influenza Virus and Respiratory Syncitial Virus InfectionsCompletedNCT03757546
• A Study of An Adjuvanted Inactivated H7N9 Influenza VaccineCompletedNCT03755427Phase 2
• Oseltamivir Versus Paracetamol for Influenza-like Illness During the Influenza SeasonStatus unknownNCT03754686Phase 4
• TITRE III: Influenza B Immunogenicity InvestigationActive, not recruitingNCT03753347Phase 4
• Analysis of Antigen Specific B Cell Responses to Immunization With Influenza Virus VaccineCompletedNCT03748524Early Phase 1
• Herd Immunity and Influenza Vaccine UptakeCompletedNCT03748160Not applicable
• Two Doses of GHB04L1 for Pandemic Influenza Prophylaxis in Healthy AdultsCompletedNCT03745274Phase 1
• A Clinical Trial of A Quadrivalent Influenza VaccineCompletedNCT03744104Phase 3
• Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy AdultsCompletedNCT03743688
• Reactogenicity, Safety and Immunogenicity of a LAIV А/17/Hong Kong/2017/75108 H7N9 Influenza VaccineStatus unknownNCT03739229Phase 1
• Resistance Exercise to Improve Flu Vaccine for Older AdultsCompletedNCT03736759Not applicable
• A Study to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza VaccineCompletedNCT03718468Phase 3
• Immunogenicity and Safety of NBP607-QIV Compared to Agrippal in Children Aged 6 to 35 MonthsCompletedNCT03704740Phase 3
• Investigating the Effectiveness of a Seasonal Influenza Vaccination Promotion Campaign for Members of a Non-Profit, Community-Based Health Insurance Plan: 2018-2019Status unknownNCT03700281Not applicable
• Reducing the Burden of Influenza After Solid-Organ TransplantationCompletedNCT03699839Phase 2/3
• Probiotic and Influenza Vaccination to Reducing Influenza-like Illness Incident in ElderlyCompletedNCT03695432Phase 4
• CT18 Infant Influenza Priming Study in Vaccine Naive InfantsCompletedNCT03669627Phase 2
• A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy SubjectsCompletedNCT03657719Phase 2
• Immune Response and Risk of Side Effects After Influenza Vaccination in AthletesCompletedNCT03654937Phase 4
• The Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVacCompletedNCT03651544Phase 1
• An Improvement Project Around Staffs' Influenza Vaccine UptakeCompletedNCT03637036Not applicable
• Effect of Early Antiviral Therapy on Duration of Cough in Flu PatientsStatus unknownNCT03618407
• Adjuvanted Influenza Vaccination Year 2 Follow-On SurveyCompletedNCT03599739
• Randomized Influenza Vaccine Evaluation of Immune ResponseCompletedNCT03598439Phase 4
• Safety and Immune Response of Increasing Doses of OVX836 After Intramuscular or Intranasal Administrations in Healthy SubjectsCompletedNCT03594890Phase 1
• Influenza Vaccination in Patients Receiving Immune Checkpoint InhibitorCompletedNCT03590808Not applicable
• A Study in Healthy Adults to Assess Priming With Antigenically Mismatched Live Attenuated A/H7N3 Influenza Virus Vaccine Followed by Inactivated A/H7N9 Influenza Virus VaccineCompletedNCT03581903Phase 1
• Preventive Effectiveness, Safety and Immunogenicity of a Allantoic Split Inactivated Seasonal Influenza VaccineCompletedNCT03572491Phase 3
• The Effect of Live Attenuated Inactivated Influenza Vaccine on Experimental Human Pneumococcal Carriage StudyCompletedNCT03502291Phase 4
• H5N1 With or Without Topical Aldara in Healthy AdultsCompletedNCT03472976Phase 1
• Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17.CompletedNCT03460743Phase 3
• The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and InfectionCompletedNCT03453801Phase 1
• Prospective System Analysis of the Seasonal Influenza Virus Transmissions and Evolution in the City of Basel BaselCompletedNCT03451656
• Safety of 4Fluart ID Suspension for Injection in Adult SubjectsCompletedNCT03448705Phase 1
• Immunogenicity and Safety for 'IL-YANG Quadrivalent Influenza Vaccine' in Healthy Korean Children and AdolescentsCompletedNCT03445468Phase 3
• Increasing the Uptake of Influenza and Pneumococcal Vaccines Among High-Risk Adult Patients Through GP ClinicsCompletedNCT03445117Not applicable
• Afluria Pregnancy RegistryCompletedNCT03442582
• XC8 in the Treatment of Patients With Acute Respiratory Viral InfectionCompletedNCT03441373Phase 2/3
• Flucelvax (TIVc or QIVc) Pregnancy RegistryCompletedNCT03438487
• Safety of a Single Dose or Two Doses of Shenzhen Quadrivalent Influenza VaccineCompletedNCT03430089Phase 1
• QuickVue Influenza A + B Test Field StudyCompletedNCT03417869
• Optimizing the Influenza Clinical Decision Support ToolCompletedNCT03415425Not applicable
• Nosocomial Influenza Surveillance 2018 - 2022Status unknownNCT03413228
• Evaluation of Metabolic Predictors of Influenza Vaccine Immune Response in the Singapore Elderly Population - the DYNAMIC TrialStatus unknownNCT03399357
• Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I)TerminatedNCT03396575Phase 1
• A Pharmacokinetics Study of Favipiravir in Patients With Severe InfluenzaCompletedNCT03394209Phase 2
• Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018)CompletedNCT03392207
• Invasive Pulmonary Aspergillosis Complicating Influenza InfectionCompletedNCT03391492
• Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza VaccineCompletedNCT03391193Phase 3
• A Clinical Trail Of An Adjuvanted Inactivated H7N9 Influenza VaccineCompletedNCT03369808Phase 1/2
• Epidemiology of Post-influenza Bacterial Pneumonia Due to a Panton-Valentine Leukocidin Positive Staphylococcus AureusStatus unknownNCT03367624
• Sub Populations of Immune Cells in Influenza A and B PatientsStatus unknownNCT03366402
• Influenza Management With Polyherbal FormulationStatus unknownNCT03365336Not applicable

← Influenza, Human overview